5-Cog 2.0: A Pragmatic Clinical Trial

Launched by ALBERT EINSTEIN COLLEGE OF MEDICINE · Aug 23, 2022

Keywords

ClinConnect Summary

The 5-Cog 2.0 clinical trial is studying a new, quick way to identify cognitive impairment, which can be related to conditions like dementia, especially in older adults. Many people in primary care settings may not get diagnosed properly, particularly those from underserved communities. The trial will test a brief assessment called the 5-Cog, which takes less than five minutes to complete and doesn’t require additional input from family members. This assessment aims to improve the detection of cognitive issues in older adults visiting primary care clinics in the Bronx and Indiana.

To participate, individuals must be 65 years or older and have some concerns about their cognitive abilities, like memory or thinking skills. However, those who have already been diagnosed with dementia or live in permanent nursing facilities cannot join. If you decide to participate, you can expect to take the 5-Cog assessment and possibly receive enhanced care based on the results. The trial aims to ensure that when cognitive issues are identified, there are follow-up actions to improve patient care, particularly for those in communities that often face health disparities.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. 65 years and older
• • 2. Presence of cognitive concerns
• • 3. English or Spanish speaking.
• • 4. Able to see and hear well enough to complete assessments.
• Exclusion Criteria:
• • 1. Prior diagnosis of dementia (documented in the electronic medical record or reported by physicians).
• • 2. Permanent nursing facility residents.